SOEDAK2009 --- PREPARE FOR THE LONG RUN

TABLE: Inhalte   Printer Friendly

 Search
  Show all  Advanced Search 
    

First  Previous  1  2  3  4  5  6  7  8  9  10  11-15  Next  Last       Records 161 to 180 of 285
Titel (*)
Autor (*)
  
Prevalence of virologic failure in HIV-1-infected patients treated with antiretroviral therapy (ART) - results from a German multicenter cohort-study (VIREMIA)
Axel Baumgarten1, Stephan Klauke2, Knud Schwere3, Christoph Mayr4, Hans Jäger5, Pavel Khaykin6, Cam-Tuan Tran7, Markus Bickel6
 View
Veränderungen des HIV-1-Mutationsprofils vor Therapiebeginn in Abhängigkeit von der Zeit
Stefan Reuter1, Rolf Kaiser2, Mark Oette3, Melanie Balduin2, Björn Jensen1, Dieter Häussinger1, Nadine Sichtig2
 View
Use of tenofovir disoproxil fumarate (TDF) during pregnancy: an analysis from the Antiretroviral Pregnancy Registry (APR)
Bruce Olmscheid1, Sandra Hertling2, Sherry Zhang1
 View
Efficacy of a computerised physician reminder system to control CHD risk factors in HIV-patients receiving cART (Swiss HIV Cohort Study)
Heiner C. Bucher1, Martin Rickenbach2, James Young1, Tracy Glass1, Yannick Valley2, Enos Bernasconi3, Matthias Cavassini4, Christoph Fux5, Véronique
 View
Prevalence of minority HIV-1 NNRTI drug resistance mutation K103N in antiretroviral treatment-naïve patients
Patrick Braun1, Robert Ehret1, Christian Höhn1, Frank Wiesmann1, Heribert Knechten1
 View
Tenofovir- and protease inhibitor-use are associated with an Increased prevalence of proximal renal tubular dysfunction in the SHCS
Christoph Andreas Fux1, Milos Opravil2, Matthias Cavassini3, Alexandra Calmy4, Ben Spycher5, Barbara Hasse2, Patrick Schmid6, Marcel Stöckle7, Vanin
 View
12 h pharmacokinetics in HIV mono- and HIV/HCV co-infected patients
Martin Vogel1, Norbert Bertram2, Jan-Christian Wasmuth1, Christoph Wyen3, Esther Voigt1, Carolynne Schwarze-Zander1, Thomas Sudhop4, Gerd Fätkenheuer3
View
Impact of resistant HIV on first line treatment response in therapy naive patients of the German HIV-1-seroconverter cohort
Barbara Bartmeyer1, Claudia Houareau1, Claudia Kücherer2, Christian Kollan1, Johanna Werning1, Osamah Hamouda1, Deutsche HIV-1 Seroconverter Studiengruppe
 View
Quantitative and qualitative mtDNA-lesions with mitochondrial dysfunction in multiple organs after HAART-associated fatal lactacidosis
Jan Thoden1, Dirk Lebrecht1, Nils Venhoff1, Jens H Neumann2, Klaus Müller3, Ulrich A Walker1
 View
Coronary heart disease and risk factors in HIV-1-infected patients in correlation to abacavir treatment
Thomas Harrer1, Almut Taubald1, Ellen G. Harrer1, Christina Schaub-Koch1, Anja Reisch1, Sandra M. Müller1, Bernd Spriewald2, Mohamed Marvan3, Frank
View
Detection of abacavir hypersensitivity by ELISpot method
Stefan Esser1, Robert Jablonka1, Falko M. Heinemann2, Monika Lindemann2
 View
A German cohort of 54 HIV and LPV/r exposed pregnancies - pharmacokinetics, placental transfer and pregnancy outcome
Milena Sovric1, Andrea Gingelmaier1, Ralph Kaestner1, Tobias Weissenbacher1, Ionnis Mylonas1, Klaus Friese1
 View
Frequent pyridoxal phosphate (PLP) inadequacy associated with the use of RTV-boosted protease inhibitors
Hans-Jürgen Stellbrink1,2, Andreas Lämmel2, Christian Noah2
 View
Transmission of a highly RT-and protease-inhibitor resistant virus demonstrates the importance of resistance analysis prior to initiation of HAART
Thomas Harrer1, Klaus Korn2, Hauke Walter2, Sandra M. Müller1, Werner Matek3, Ellen G. Harrer1, German Competence Network for HIV/AIDS
 View
Frequency of lipodystrophy in a large observational cohort using either LPV/r or EFV
Jan van Lunzen1, Ramona Volkert-Pauli2, Stefan Hansen3, Martin Hower4, Clemens Scheidegger5, Antonius Mutz6, Andreas Trein7
 View
The definition "acute" does not influence SVR in HIV-positive individuals treated with pegylated interferon +/- interferon after acute HCV infection
Martin Vogel1, Axel Baumgarten2, Kevin Ummard3, Michael Rausch4, Knud Schewe5, Christoph Mayr6, Dietmar Schranz7, Albert Theisen8, Heiko Jessen9
View
Leberparenchymschaden bei HIV-1-Monoinfizierten unter antiretroviraler Therapie (ART) und chronischer Transaminasenerhöhung
Patrick Ingiliz1, Marc-Antoine Valantin2, Claudine Duvivier3, Fadia Medja4, Stephanie Dominguez3, Frédéric Charlotte5, Roland Tubiana3, Thierry Poynard
View
Methicillin resistant Staphylococcus aureus and ESBL-producing Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca isolated from HIV infected inpatients
Hartmut Stocker1, Bettina Eberspaecher2, Hubert Schulbin1, Christian Traeder1, Sonja Swidsinski3, Keikawus Arasteh1
 View
Vergleich von TST, QuantiFERON-Gold In-Tube und T-Spot.TB bei HIV-Patienten
Christoph Stephan1, Timo Wolf1, Udo Götsch2, Oswald Bellinger2, Gabriele Nisius1, Gerhard Oremek3, René Gottschalk2, Sonja Stark2, Hans-Reinha
 View
Anales Dysplasiescreening bei HIV-infizierten Frauen
Andrea Gingelmaier1, Tobias Weissenbacher1, Kästner Ralph1, Bernd Kost1, Thomas Grubert2, Sovric Milena1, Florian Bergauer1
 View